CN107281397A - A kind of powder for treating apoplexy sequelae - Google Patents

A kind of powder for treating apoplexy sequelae Download PDF

Info

Publication number
CN107281397A
CN107281397A CN201710435712.XA CN201710435712A CN107281397A CN 107281397 A CN107281397 A CN 107281397A CN 201710435712 A CN201710435712 A CN 201710435712A CN 107281397 A CN107281397 A CN 107281397A
Authority
CN
China
Prior art keywords
parts
powder
ginseng
portions
grams
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710435712.XA
Other languages
Chinese (zh)
Inventor
李梁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sansui People's Hospital
Original Assignee
Sansui People's Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sansui People's Hospital filed Critical Sansui People's Hospital
Priority to CN201710435712.XA priority Critical patent/CN107281397A/en
Publication of CN107281397A publication Critical patent/CN107281397A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/24—Mucus; Mucous glands; Bursa; Synovial fluid; Arthral fluid; Excreta; Spinal fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/648—Myriapods, e.g. centipedes or millipedes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/898—Orchidaceae (Orchid family)
    • A61K36/8988—Gastrodia

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Insects & Arthropods (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Neurology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention discloses a kind of powder for treating apoplexy sequelae, it is made up of following bulk drugs by quality proportioning：30 60 parts of pseudo-ginseng, 60 90 parts of dragon's blood, 10 30 parts of centipede, 10 20 parts of scorpio, 10 20 parts of rhizoma Gastrodiae, 8 15 parts of Tabasheer, 8 15 parts of grass-leaved sweetflag, 10 20 parts of leech, 10 60 parts of American Ginseng, 40 60 parts of ground bettle, 30 60 parts of red ginseng, 36 parts of aspongopus, 10 15 parts of excrementum pteropi；Proportionally mix, beat powder, cross 65 mesh medicines sieve, closed lucifuge is stored for future use, each taking 24 grams, twice a day, and thin rice gruel or rhizoma imperatae soup take.This powder is by the reasonable compatibility of each component medicinal material, and with scattered silt hemostasis, ceases wind antispastic, nourishing qi to stop effect can effectively treat hemorrhagic and ischemic apoplexy sequela, be within five weeks a course for the treatment of, and effective percentage 92% does not have other side effects during medication.

Description

A kind of powder for treating apoplexy sequelae
Technical field
The present invention relates to a kind of powder for treating apoplexy sequelae, belong to the field of Chinese medicines.
Background technology
Apoplexy be one group using cerebral ischemic and heamorrhagic lesions symptom as the disease of main clinical manifestation, also known as cerebral apoplexy or Cerebrovas-cularaccident, with high case fatality rate and disability rate, is broadly divided into hemorrhagic cerebral apoplexy（Cerebral hemorrhage or cavum subarachnoidale go out Blood）And ischemia apoplexy（Cerebral infarction, cerebral thrombosis）Two major classes.Hemorrhagic cerebral apoplexy Infant Mortality is very high, there are about half Number patients are most in survivor to leave different degrees of dyskinesia, cognitive disorder, speech and swallow barrier in dead in the morbidity a few days The sequelae such as hinder.Using hemiplegia as main sequelae on ischemia apoplexy patient clinical.Multiple to be born in after 50 years old, male is slightly more In women.
China is also accumulated from rich experience as Chinese Traditional Medicine big country, in the treatment wind sequelae, traditional in recent years The traditional Chinese medical science disclose plurality of Chinese formula, the Chinese medicine preparation for treating apoplexy sequelae is different, therapeutic effect also phase not to the utmost Together, therapeutic effect respectively has feature.
The content of the invention
In view of the deficiencies of the prior art, the present invention is intended to provide a kind of powder for treating apoplexy sequelae, Ke Yiyou Effect treatment hemorrhagic and ischemia apoplexy sequelae.
A kind of the technical solution adopted by the present invention, powder for treating apoplexy sequelae presses quality proportioning by following bulk drugs It is made：
30-60 parts of pseudo-ginseng 60-90 parts of dragon's blood 10-30 parts of centipede 10-20 parts of scorpio 8-15 parts of Tabasheer of 10-20 parts of rhizoma Gastrodiae 8-15 portions of grass-leaved sweetflag 10-20 portions of leech 10-60 portions of American Ginseng 40-60 portions of ground bettle 3-6 parts of aspongopus of 30-60 portions of red ginseng 10-15 parts of excrementum pteropi；
Said medicine is proportionally mixed, beats powder, crosses 65 mesh medicines sieve, and closed lucifuge is stored for future use, each taking 2-4 grams, one day Twice, thin rice gruel or rhizoma imperatae soup take.
Herbal pharmacology of the present invention：
Pseudo-ginseng
Nature and flavor：Sweet, slight bitter, temperature；
Channel tropism：Enter liver, stomach；
Major function：Scattered silt is stopped blooding, detumescence ding-tong.
Dragon's blood
Nature and flavor：It is sweet, salty, put down；
Channel tropism：The thoughts of returning home, Liver Channel；
Major function：Promoting blood circulation analgesic therapy, removing blood stasis and hemostasis, myogenic sore.
Centipede
Nature and flavor：It is pungent, temperature；
Channel tropism：Return liver warp；
Major function：Ceases wind antispastic, removes obstruction in channels to relieve pain, dispersing pathogen accumulation.
Scorpio
Nature and flavor：It is pungent, put down；
Channel tropism：Return liver warp；
Major function：Ceases wind antispastic, removes obstruction in channels to relieve pain, dispersing pathogen accumulation.
Rhizoma Gastrodiae
Nature and flavor：It is sweet, put down；
Channel tropism：Return liver warp；
Major function：Inflammation Zhijing, suppressing liver-YANG, dispelling wind and removing obstruction in the meridians.
Tabasheer
Nature and flavor：It is sweet, tremble with fear；
Channel tropism：The thoughts of returning home, Liver Channel；
Major function：Heat phlegm, cool heart arresting convulsion.
Grass-leaved sweetflag
Nature and flavor：Pungent, hardship, temperature；
Channel tropism：The thoughts of returning home, stomach；
Major function：Have one's ideas straightened out slit phlegm, inducing resuscitation intelligence development, dampness elimination appetizing.
Leech
Nature and flavor：Salty, hardship, puts down；
Channel tropism：Return liver warp；
Major function：Blood-breaking is stimulated the menstrual flow, by Yu Xiao Disorder.
American Ginseng
Nature and flavor：Sweet, slight bitter, it is cool；
Channel tropism：The thoughts of returning home, lung, kidney channel；
Major function：Boosting qi and nourishing yin, clearing heat and promoting fluid.
Red ginseng
Nature and flavor：Sweet, slight bitter, temperature；
Channel tropism：Returns spleen, lung, the heart, kidney channel；
Major function：Reinforce vital energy, veins takes off admittedly, nourishing qi to stop.
Ground bettle
Nature and flavor：It is salty, tremble with fear；
Channel tropism：Return liver warp；
Major function：Blood-breaking is by silt, reunion of fractured tendons and bones.
Aspongopus
Nature and flavor：It is salty, temperature；
Channel tropism：Return liver, spleen, kidney channel；
Major function：Regulating qi-flowing for relieving pain, middle benefit gas is supporing yang.
Excrementum pteropi
Nature and flavor：It is sweet, temperature；
Channel tropism：Return liver warp；
Major function：Promoting blood circulation to remove blood stasis.
This powder is by the reasonable compatibility of each component medicinal material, and with scattered silt hemostasis, ceases wind antispastic, nourishing qi to stop effect can It is within five weeks a course for the treatment of effectively to treat hemorrhagic and ischemic apoplexy sequela, it is efficient through clinical treatment observation for many years 92%, there is no other side effects during medication.
Embodiment
Embodiment 1
60 grams of pseudo-ginseng, 80 grams of dragon's blood, 15 grams of centipede, 10 grams of scorpio, 15 grams of rhizoma Gastrodiae, 10 grams of Tabasheer, 6 grams of American Ginsengs 30 of leech Gram 15 grams of ground bettle, 30 grams of red ginseng, 3 grams of aspongopus, 10 grams of excrementum pteropi；Said medicine proportionally mixes, beats powder, crosses 65 mesh Medicine is sieved, and closed lucifuge is stored for future use, each taking 2-4 grams, twice a day, and rhizoma imperatae soup takes.
Model case
1st, dragon certain, man, 71 years old, suffer from after hemorrhagic cerebral apoplexy, it is handicapped, can't take care of oneself, medication 45 days after, can be slow Freely walk, life can take care of oneself.
2nd, poplar, man, 62 years old, suffers from after ischemia apoplexy, slow in action to speak with a lisp, after taking medicine 30 days, and walking improves, Speech also has improvement.

Claims (1)

1. a kind of powder for treating apoplexy sequelae, it is characterised in that be made up of following bulk drugs by quality proportioning：
30-60 parts of pseudo-ginseng 60-90 parts of dragon's blood 10-30 parts of centipede 10-20 parts of scorpio 8-15 parts of Tabasheer of 10-20 parts of rhizoma Gastrodiae 8-15 portions of grass-leaved sweetflag 6-20 portions of leech 10-60 portions of American Ginseng 10-30 portions of ground bettle 3-6 parts of aspongopus of 30-60 portions of red ginseng 10-15 parts of excrementum pteropi；
Said medicine is proportionally mixed, beats powder, crosses 65 mesh medicines sieve, and closed lucifuge is stored for future use, each taking 2-4 grams, one day Twice, thin rice gruel or rhizoma imperatae soup take.
CN201710435712.XA 2017-06-11 2017-06-11 A kind of powder for treating apoplexy sequelae Pending CN107281397A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710435712.XA CN107281397A (en) 2017-06-11 2017-06-11 A kind of powder for treating apoplexy sequelae

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710435712.XA CN107281397A (en) 2017-06-11 2017-06-11 A kind of powder for treating apoplexy sequelae

Publications (1)

Publication Number Publication Date
CN107281397A true CN107281397A (en) 2017-10-24

Family

ID=60097085

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710435712.XA Pending CN107281397A (en) 2017-06-11 2017-06-11 A kind of powder for treating apoplexy sequelae

Country Status (1)

Country Link
CN (1) CN107281397A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112220877A (en) * 2020-11-13 2021-01-15 吉林省第二荣复军人医院 Traditional Chinese medicine preparation for treating cerebral apoplexy in convalescent period and preparation method thereof
CN114246915A (en) * 2022-01-25 2022-03-29 汪新水 Traditional Chinese medicine composition for preventing and treating stroke sequela and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1171255A (en) * 1996-12-05 1998-01-28 滕盛斌 Chinese medicine for preventing and curing apoplexy and compounding process thereof
CN105213818A (en) * 2015-10-30 2016-01-06 王玉龙 A kind of Chinese medicine composition being used for the treatment of apoplexy sequela and preparation method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1171255A (en) * 1996-12-05 1998-01-28 滕盛斌 Chinese medicine for preventing and curing apoplexy and compounding process thereof
CN105213818A (en) * 2015-10-30 2016-01-06 王玉龙 A kind of Chinese medicine composition being used for the treatment of apoplexy sequela and preparation method thereof

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
《中医大辞典》编辑委员会: "《中医大辞典 基础理论分册 （试用本）》", 31 January 1982, 人民卫生出版社 *
佚名: ""三七块50克，土元25克，元胡25克，水蛭50克，血竭25克，西洋参50克，打粉喝，这个药方主治什么？有什么用"", 《拇指医生》 *
来明等: "三七水蛭粉配合针刺治疗中风后遗症33例临床观察", 《医药产业资讯》 *
梁宏正: "《梁剑波》", 31 December 2012, 中国中医药出版社 *
武健东: "名医郑邦本治疗中风后遗症的名方", 《求医问药》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112220877A (en) * 2020-11-13 2021-01-15 吉林省第二荣复军人医院 Traditional Chinese medicine preparation for treating cerebral apoplexy in convalescent period and preparation method thereof
CN114246915A (en) * 2022-01-25 2022-03-29 汪新水 Traditional Chinese medicine composition for preventing and treating stroke sequela and preparation method thereof
CN114246915B (en) * 2022-01-25 2022-11-08 汪新水 Traditional Chinese medicine composition for preventing and treating stroke sequela and preparation method thereof

Similar Documents

Publication Publication Date Title
CN107281397A (en) A kind of powder for treating apoplexy sequelae
CN102772578B (en) Traditional Chinese composition for treating beriberi
CN104225249A (en) Oral-administration fracture-setting traditional Chinese medicine for treating fracture
CN102218086A (en) Traditional Chinese medicine ointment for treating hemorrhoids
CN104667035A (en) Medicament for treating gout
CN102512519A (en) Medicinal moxa roll for treating osteoporosis and preparation method thereof
CN100381147C (en) Rapid-acting bone wound capsules and preparation thereof
CN106038743A (en) Blood pressure reducing electuary, and preparation method and application thereof
CN104474153A (en) Medicine used for diminishing inflammation, relieving pain,eliminating blood stasis and promoting tissue regeneration
CN104547032A (en) Chinese patent medicine for blood stasis stagnating syndrome
CN107281353A (en) A kind of Chinese medicine of promotion nerve regneration
CN106074784A (en) The Chinese medicine for the treatment of coronary heart disease and myocardial ischemia
CN103356951B (en) A kind of Chinese medicine composition for the treatment of cardiac blood supply deficiency
CN107375547A (en) A kind of treat triggers the violent Chinese medicine of headache by chill
CN103120768A (en) Medicament for treating vital myocarditis and cardiomyopathy
CN102008648A (en) External washing traditional Chinese medicine for treating femoral head necrosis
CN101428095A (en) Medicinal liquor for treating hemiplegia and preparation method thereof
CN104435217B (en) A kind of external application powdered medicine ' Tongluosan '
CN104147576B (en) A kind of external application medicated wine treating ischemic heart desease
CN104645224A (en) Traditional Chinese medicine preparation for treating costal chondritis
CN112451641A (en) Traumatic injury treating bitter ointment and preparation method thereof
CN104173777A (en) Traditional Chinese medicine for treating hemiplegia
CN103599441A (en) Externally-applied traditional Chinese medicine ointment for treating traumatic injury, catagma, old rheumatalgia and trauma and preparation method thereof
CN103948682A (en) Traditional Chinese medicine for treating arrhythmia caused by insufficiency of heart blood
CN103239584B (en) Traditional Chinese medicine for treating lumbar disc herniation and lumbar vertebrae hyperosteogeny, and preparation method of traditional Chinese medicine

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20171024